Reliability of PSA testing remains unclearBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7417.750 (Published 25 September 2003) Cite this as: BMJ 2003;327:750
- Stefano Ciatto, head of department (email@example.com)
- Centro per lo Studio e la Prevenzione Oncologica, Viale A Volta, I-50131 Florence, Italy
EDITOR–Gottlieb's news item reports that the reliability of prostate specific antigen (PSA) testing is poor.1 Necropsy studies have for a long time shown that the prostate of men over 50 harbours cancer in about 30% of cases, but only 8-10% develop a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial